How much debt does Rein Therapeutics have?

Rein Therapeutics had total debt of $0.00 as of Mar 31, 2026, against $3.21M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $0.00 a year earlier.

What are Rein Therapeutics's total assets?

Rein Therapeutics reported total assets of $24.16M as of Mar 31, 2026, down 65.1% from $69.24M a year earlier. Total liabilities were $7.24M.

What is Rein Therapeutics's shareholders' equity?

Rein Therapeutics's shareholders' equity was $16.92M as of Mar 31, 2026.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry.

Rein Therapeutics (RNTX) Balance Sheet: Assets & Liabilities

Rein Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Rein Therapeutics Inc. (RNTX) - Annual data in millions USD
Breakdown	FY 2025	FY 2025	FY 2024	FY 2024	FY 2023	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Mar 2026	Dec 2025	Mar 2025	Dec 2024	Mar 2024	Dec 2023	Mar 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	3.22	3.22	12.87	12.87	17.31	17.31	5.19	5.19	3.60	7.05	5.31	10.64
Short-Term Investments	0.00	-	0.00	-	0.00	-	16.05	16.05	42.33	6.76	12.97	10.06
Cash & Short-Term Investments	3.22	3.22	12.87	12.87	17.31	17.31	21.24	21.24	45.93	13.81	18.28	20.70
Accounts Receivable	0.00	-	0.00	-	0.00	-	0.00	-	0.00	0.00	0.00	0.00
Inventory	0.00	-	0.00	-	0.00	-	0.00	-	0.00	0.00	0.00	0.00
Other Current Assets	1.11	1.11	0.79	0.79	0.95	0.88	0.63	0.61	2.22	1.93	1.27	1.08
Total Current Assets	4.33	4.33	13.66	13.66	18.27	18.27	21.87	21.87	48.18	16.33	19.55	21.78
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	-	0.00	0.00	0.02	0.07	0.11	0.11	0.28	0.02	6.36	7.29
Long-Term Investments	0.00	-	0.00	-	0.00	-	0.00	-	0.00	0.00	0.57	0.57
Goodwill	6.33	6.33	0.00	6.33	6.33	6.33	0.00	-	0.00	0.00	0.00	0.00
Intangible Assets	13.50	13.50	48.53	42.20	79.20	79.20	0.00	-	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	2.19	2.19	0.02	0.02	0.02	0.00	0.57	0.68
Total Non-Current Assets	19.83	19.83	55.58	48.53	87.74	87.74	0.13	0.13	0.30	0.02	6.92	8.54
Total Assets	24.16	24.16	69.24	62.19	106.01	106.01	22.01	22.01	48.48	16.34	26.47	30.31
Current Liabilities
Accounts Payable	3.98	3.98	0.91	0.91	1.19	1.19	1.72	1.72	1.21	1.60	1.45	1.73
Short-Term Debt	0.00	-	0.00	-	0.05	-	0.03	-	0.09	0.17	0.89	0.00
Current Portion of Long-Term Debt	-	-	-	-	-	-	-	-	-	0.17	-	-
Accrued Liabilities	-	2.20	-	4.84	-	3.15	-	1.63	3.21	1.95	-	-
Deferred Revenue	0.00	-	0.00	-	0.00	-	0.00	-	0.00	0.00	3.59	0.00
Other Current Liabilities	2.20	0.10	4.84	0.12	3.15	0.21	1.63	0.18	0.06	0.24	3.50	3.64
Total Current Liabilities	6.18	6.18	5.75	5.75	4.39	4.39	3.38	3.38	4.51	3.96	5.84	5.37
Non-Current Liabilities
Long-Term Debt	0.00	-	0.00	-	0.00	-	0.00	-	0.07	0.22	4.59	5.34
Deferred Tax Liabilities	1.06	1.06	8.82	1.77	3.33	3.33	0.00	-	0.00	0.00	1.65	0.00
Other Non-Current Liabilities	0.00	1.06	0.28	2.05	91.41	3.33	0.00	-	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	1.06	1.06	9.10	2.05	94.74	3.33	0.00	-	0.07	0.22	4.59	5.34
Total Liabilities	7.24	7.24	14.85	7.80	99.12	7.71	3.38	3.38	4.58	4.18	10.43	10.71
Stockholders' Equity
Common Stock	0.11	0.11	0.11	0.11	0.09	0.09	0.09	0.09	0.09	0.04	0.03	0.02
Retained Earnings	-401.27	-401.27	-351.40	-351.40	-288.52	-288.52	-272.79	-272.79	-245.46	-219.29	-198.14	-168.49
Accumulated Other Comprehensive Income	-0.06	-0.06	-0.02	-0.02	-0.06	-0.06	-0.05	-0.05	-0.01	0.00	0.01	0.00
Additional Paid-in Capital	373.13	373.13	360.70	360.70	295.38	295.38	291.37	291.37	289.28	231.41	214.15	188.08
Shares Outstanding	-	27.55	-	21.67	-	4.89	-	4.54	4.53	-	-	-
Total Stockholders' Equity	16.92	16.92	54.39	54.39	6.89	98.30	18.62	18.62	43.90	12.16	16.05	19.60
Total Liabilities & Equity	24.16	24.16	69.24	62.19	106.01	106.01	22.01	22.01	48.48	16.34	26.47	30.31

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Rein Therapeutics Balance Sheet Analysis

Frequently Asked Questions About Rein Therapeutics Balance Sheet